J. Mion

Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.

V. Boulay, G. Guillon, S. Stoev, 2011, Journal of medicinal chemistry.

Pharmacological characterization of FE 201874, the first selective high affinity rat V1A vasopressin receptor agonist

E. Galibert, G. Guillon, Z. Meraihi, 2013, British journal of pharmacology.

V1b and CRHR1 receptor heterodimerization mediates synergistic biological actions of vasopressin and CRH.

V. Boulay, G. Guillon, D. Devost, 2012, Molecular endocrinology.

Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice

P. Sokoloff, D. Rognan, J. Pin, 2018, Nature Communications.

Characterization of a functional V 1B vasopressin receptor in the male rat kidney, evidence for crosstalk between V 1B and V 2 receptor signaling pathways

C. S. Gal, G. Guillon, C. Llorens-Cortes, 2022 .

Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice

P. Sokoloff, D. Rognan, J. Pin, 2018, Nature Communications.